v3.23.3
Stock-Based Compensation - Schedule of Stock Option and Restricted Stock Unit Activity (Details)
$ / shares in Units, shares in Millions, $ in Millions
1 Months Ended 9 Months Ended
May 31, 2023
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Shares Available for Grant    
Balances at beginning of period (in shares)   108.0
Granted (in shares)   (11.0)
Increase in shares available for grant (in shares)   32.0
Exercised/Vested (in shares)   3.0
Canceled (in shares)   2.0
Balances at end of period (in shares)   134.0
Number of Shares    
Balances at beginning of period (in shares)   22.0
Granted (in shares)   1.0
Increase in shares available for grant (in shares)   0.0
Exercised/Vested (in shares) (11.2) (16.0)
Canceled (in shares)   0.0
Balances at end of period (in shares)   7.0
Weighted- Average Exercise Price    
Balances at beginning of period (in USD per share) | $ / shares   $ 23.41
Granted (in USD per share) | $ / shares   122.41
Increase in shares available for grant (in USD per share) | $ / shares   0
Exercised/Vested (in USD per share) | $ / shares   4.93
Canceled (in USD per share) | $ / shares   0
Balances at end of period (in USD per share) | $ / shares   $ 69.66
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Options outstanding (in shares)   7.0
Options exercisable (in shares)   6.0
Options outstanding (in USD per share) | $ / shares   $ 69.66
Options excisable (in USD per share) | $ / shares   $ 57.21
Options outstanding, weighted-average remaining contractual life (in years)   5 years 9 months 29 days
Options exercisable, weighted-average remaining contractual life (in years)   5 years 21 days
Options outstanding, aggregate intrinsic value | $   $ 544
Options exercisable, aggregate intrinsic value | $   $ 480
RSUs    
Number of Shares    
Balances at beginning of period (in shares)   34.0
Granted (in shares)   10.0
Increase in shares available for grant (in shares)   0.0
Exercised/Vested (in shares)   (9.0)
Canceled (in shares)   (2.0)
Balances at end of period (in shares)   33.0
Weighted- Average Grant Date Fair Value    
Balances at beginning of period (in USD per share) | $ / shares   $ 77.07
Granted (in USD per share) | $ / shares   121.42
Increase in shares available for grant (in USD per share) | $ / shares   0
Exercised/Vested (in USD per share) | $ / shares   98.85
Canceled (in USD per share) | $ / shares   119.46
Balances at end of period (in USD per share) | $ / shares   $ 83.06